Based upon the Mat1a-KO metabolome that is associated with NASH, serum of biopsy proven NAFLD patients was also analyzed and compared with Mat1a-KO mouse findings. Here, MAT1A is linked to metabolic dysfunction-associated steatotic liver disease.